BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gong AGW, Duan R, Wang HY, Kong XP, Dong TTX, Tsim KWK, Chan K. Evaluation of the Pharmaceutical Properties and Value of Astragali Radix. Medicines (Basel) 2018;5:E46. [PMID: 29883402 DOI: 10.3390/medicines5020046] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Gong G, Yu H, Zheng Y, Qi B, He H, Yin T, Dong TT, Tsim KW. Astragaloside IV, a saponin from Astragalus membranaceus var. mongholicus, induces expressions of heme recycle proteins via signaling of Nrf2/ARE in cultured macrophages. J Ethnopharmacol 2021;265:113389. [PMID: 32920134 DOI: 10.1016/j.jep.2020.113389] [Reference Citation Analysis]
2 Shi YH, Zhang XL, Ying PJ, Wu ZQ, Lin LL, Chen W, Zheng GQ, Zhu WZ. Neuroprotective Effect of Astragaloside IV on Cerebral Ischemia/Reperfusion Injury Rats Through Sirt1/Mapt Pathway. Front Pharmacol 2021;12:639898. [PMID: 33841157 DOI: 10.3389/fphar.2021.639898] [Reference Citation Analysis]
3 Cui J, Zheng X, Yang D, Hu Y, An C, Bo Y, Li H, Zhang Y, Niu M, Xue X, Lu Y, Tang Y, Yin H, Li Z, Gao W, Wu Y. Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma. RSC Adv 2019;9:24471-82. [DOI: 10.1039/c9ra04701h] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Li Y, Duan B, Li Y, Yu S, Wang Y. The isoflavonoid calycosin inhibits inflammation and enhances beta cell function in gestational diabetes mellitus by suppressing RNF38 expression. Immunopharmacol Immunotoxicol 2020;42:366-72. [PMID: 32538204 DOI: 10.1080/08923973.2020.1782426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gong G, Zheng Y, Yang Y, Sui Y, Wen Z. Pharmaceutical Values of Calycosin: One Type of Flavonoid Isolated from Astragalus. Evid Based Complement Alternat Med 2021;2021:9952578. [PMID: 34035829 DOI: 10.1155/2021/9952578] [Reference Citation Analysis]
6 Wen J, Wang D, Wang J, Wang R, Wei S, Zhao Y. Astragali Radix Contributes to the Inhibition of Liver Fibrosis via High-Mobility Group Box 1-Mediated Inflammatory Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:5574010. [PMID: 33790974 DOI: 10.1155/2021/5574010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gong G, Zheng Y, Kong X, Wen Z. Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway. J Nat Prod 2021;84:1755-62. [PMID: 34029083 DOI: 10.1021/acs.jnatprod.1c00008] [Reference Citation Analysis]
8 Wang X, Wu M, Lai X, Zheng J, Hu M, Li Y, Li S. Network Pharmacology to Uncover the Biological Basis of Spleen Qi Deficiency Syndrome and Herbal Treatment. Oxid Med Cell Longev 2020;2020:2974268. [PMID: 32908629 DOI: 10.1155/2020/2974268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Guo Z, Lou Y, Kong M, Luo Q, Liu Z, Wu J. A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine. Int J Mol Sci 2019;20:E1463. [PMID: 30909474 DOI: 10.3390/ijms20061463] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
10 Zheng Y, Yang F, Han L, Gou X, Lian F, Liu W, Zhao L, Pang B, Zhao X, Tong X. Efficacy of Chinese Herbal Medicine in the Treatment of Moderate-Severe Painful Diabetic Peripheral Neuropathy: A Retrospective Study. J Diabetes Res 2019;2019:4035861. [PMID: 31950063 DOI: 10.1155/2019/4035861] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Fuzimoto AD, Brigo F. The "Treatise on the spleen and stomach" (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature - A hypothesis based on the analysis of clinical presentation and herbal medicine. J Tradit Complement Med 2020;10:288-300. [PMID: 32670824 DOI: 10.1016/j.jtcme.2020.02.009] [Reference Citation Analysis]
12 Ge C, He Y. In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis. Front Pharmacol 2020;11:556984. [PMID: 33041797 DOI: 10.3389/fphar.2020.556984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liang Y, Zhang Q, Zhang L, Wang R, Xu X, Hu X. Astragalus Membranaceus Treatment Protects Raw264.7 Cells from Influenza Virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway. Evid Based Complement Alternat Med 2019;2019:2971604. [PMID: 31975996 DOI: 10.1155/2019/2971604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
14 Liu X, Huang S, Wang F, Zheng L, Lu J, Chen J, Li S. Huangqi-Danshen Decoction Ameliorates Adenine-Induced Chronic Kidney Disease by Modulating Mitochondrial Dynamics. Evid Based Complement Alternat Med 2019;2019:9574045. [PMID: 30713579 DOI: 10.1155/2019/9574045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
15 Xiao LM, Cao PH, Luo ZH, Bao XF, Zhou ZQ, Li S, Zhao SS, Zheng JX, Gao H, Zhi H. Cycloartane-type triterpenoids from the root of Astragalus membranaceus var. mongholicus. J Asian Nat Prod Res 2020;22:905-13. [PMID: 32654511 DOI: 10.1080/10286020.2020.1787994] [Reference Citation Analysis]
16 Kafle B, Baak JPA, Brede C. Major bioactive chemical compounds in Astragali Radix samples from different vendors vary greatly. PLoS One 2021;16:e0254273. [PMID: 34234375 DOI: 10.1371/journal.pone.0254273] [Reference Citation Analysis]
17 Wang D, Li R, Wei S, Gao S, Xu Z, Liu H, Wang R, Li H, Cai H, Wang J, Zhao Y. Metabolomics combined with network pharmacology exploration reveals the modulatory properties of Astragali Radix extract in the treatment of liver fibrosis. Chin Med 2019;14:30. [PMID: 31467589 DOI: 10.1186/s13020-019-0251-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]